meglumine has been researched along with Shock, Septic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abbasi, I; Aguirre, C; Calvopina, M; Castillo, A; Cevallos, W; Warburg, A | 1 |
Bottoms, GD; Fessler, JF; Frauenfelder, HC; Moore, AB; Roesel, OF | 1 |
Hantson, P; Haufroid, V; Lambert, M; Luyasu, S | 1 |
3 other study(ies) available for meglumine and Shock, Septic
Article | Year |
---|---|
Coinfection of
Topics: Adult; Amphotericin B; Antiprotozoal Agents; Coinfection; Cytochromes b; Fatal Outcome; HIV; HIV Infections; Humans; Leishmania guyanensis; Leishmaniasis, Diffuse Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Protozoan Proteins; Sequence Analysis, DNA; Shock, Septic; Skin; Treatment Failure | 2017 |
Endotoxin-induced hemodynamic changes in ponies: effects of flunixin meglumine.
Topics: Animals; Anti-Inflammatory Agents; Blood Pressure; Cardiac Output; Central Venous Pressure; Clonixin; Digestive System; Endotoxins; Escherichia coli; Heart Rate; Hemodynamics; Horse Diseases; Horses; Meglumine; Nicotinic Acids; Pulmonary Circulation; Regional Blood Flow; Shock, Septic; Skin; Vascular Resistance | 1981 |
Antimony excretion in a patient with renal impairment during meglumine antimoniate therapy.
Topics: Antimony; Antiprotozoal Agents; Creatinine; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Oliguria; Organometallic Compounds; Renal Insufficiency; Shock, Septic | 2000 |